4d Molecular Therapeutics In shares owned by Legal & General Group
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in 4d Molecular Therapeutics In by Legal & General Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $497k | 25k | 20.26 |
2023-09-30 | $311k | 24k | 12.73 |
2023-06-30 | $437k | 24k | 18.07 |
2023-03-31 | $122k | 7.1k | 17.19 |
2022-12-31 | $63k | 2.8k | 22.21 |
2022-09-30 | $75k | 9.4k | 8.00 |
2022-06-30 | $66k | 9.4k | 7.01 |
2022-03-31 | $125k | 8.2k | 15.18 |
2021-12-31 | $181k | 8.2k | 21.92 |
2021-09-30 | $149k | 5.5k | 27.08 |
2021-06-30 | $20k | 814 | 24.57 |
2021-03-31 | $34k | 792 | 42.93 |